Handley Michael K — SEC Form 4 filings

SEC reporting owner CIK 1451334. 5 Form 4 filings on record with FilingPulse; latest filed 2026-05-20.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2025-02-24 to 2026-05-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Valion Bio, Inc. (VBIO)Chief Executive Officer, Director57

Form 4 filings — Handley Michael K

FiledFormIssuerReported transactionsSource
2026-05-204Valion Bio, Inc. (VBIO)Option exercise (M): 2,206 · Option exercise (M): 2,206 (derivative) @ $0EDGAR
2026-02-204Tivic Health Systems, Inc. (TIVC)Option exercise (M): 8,824 · Option exercise (M): 8,824 (derivative) @ $0EDGAR
2025-08-224/ATivic Health Systems, Inc. (TIVC)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2025-08-084Tivic Health Systems, Inc. (TIVC)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2025-02-244Tivic Health Systems, Inc. (TIVC)Grant/award (A): 600,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1451334 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →